associ
lymphopenia
cytokin
storm
inform
avail
specif
cellular
immun
respons
character
tcell
patient
acut
respiratori
distress
syndrom
spike
protein
prove
potent
tcell
antigen
specif
tcell
predominantli
produc
cytokin
novel
data
import
vaccin
design
facilit
evalu
vaccin
candid
immunogen
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
novel
coronaviru
name
identifi
caus
agent
global
outbreak
respiratori
tract
diseas
april
th
million
case
death
report
global
character
fever
cough
dyspnea
myalgia
patient
infect
result
moder
sever
acut
respiratori
distress
syndrom
ard
requir
invas
mechan
ventil
period
sever
week
patient
may
present
lymphopenia
diseas
also
associ
immun
hyperrespons
refer
cytokin
storm
transient
increas
coexpress
hladr
tcell
phenotyp
tcell
activ
respons
viral
infect
observ
concomitantli
increas
hladr
tcell
preced
resolut
clinic
symptom
nonsever
recov
patient
despit
larg
number
case
death
inform
avail
phenotyp
tcell
stimul
peripher
blood
mononuclear
cell
pbmc
eight
patient
ard
collect
three
week
admiss
intens
care
unit
icu
megapool
mp
overlap
predictionbas
peptid
cover
proteom
detect
tcell
patient
wherea
peptid
stimul
healthi
control
pbmc
sampl
collect
outbreak
show
respons
tcell
predominantli
produc
cytokin
although
cytokin
also
detect
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
includ
eight
patient
moder
sever
ard
studi
figur
patient
year
old
averag
year
mix
gender
femal
male
patient
test
posit
rtpcr
ventil
stay
icu
time
write
patient
transfer
icu
patient
deceas
patient
still
followup
patient
treat
lung
protect
ventil
use
higher
peeplow
tabl
ardsnet
restrict
volum
resuscit
receiv
antibiot
part
treatment
regim
aim
select
decontamin
digest
tract
antivir
immunomodulatori
drug
use
patient
icu
includ
shortli
icu
admiss
selfreport
ill
vari
day
inclus
figur
ratio
increas
patient
compar
hc
vs
hc
figur
may
reflect
migrat
tcell
respiratori
tract
pbmc
stimul
three
differ
peptid
mp
mp
two
pool
mp
contain
overlap
peptid
overlap
amino
acid
cover
entir
surfac
glycoprotein
spike
stimul
tcell
contain
hla
class
ii
predict
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
epitop
cover
viral
protein
except
specif
design
activ
tcell
two
pool
combin
contain
hla
class
predict
epitop
cover
protein
specif
design
activ
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
activ
tcell
show
mix
phenotyp
major
virusspecif
tcell
identifi
memori
em
termin
differenti
effector
emra
effector
subset
potent
produc
ifng
contain
preform
perforin
granul
immedi
antigenspecif
cytotox
home
effici
peripher
lymphoid
tissu
product
proinflammatori
cytokin
predict
sever
clinic
outcom
viral
diseas
measur
antigenspecif
product
cytokin
cell
cultur
supernat
pbmc
stimul
mp
figur
data
shown
data
shown
activ
pbmc
overlap
peptid
pool
led
strong
signific
product
cytokin
ifng
tnfa
patient
compar
hc
characterist
cytokin
also
consist
detect
albeit
low
level
level
differ
patient
hc
could
detect
antigenspecif
product
cytokin
relat
respons
mix
product
differ
patient
hc
wherea
could
detect
thu
stimul
pbmc
patient
mp
led
balanc
product
ifng
tnfa
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
measur
p
pbmc
collect
day
post
inclus
day
avail
two
patient
stimul
mp
activ
tcell
measur
express
activationinduc
cell
surfac
marker
tcell
detect
patient
frequenc
virusspecif
respond
cell
increas
significantli
time
anova
repeat
measur
p
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
collect
data
provid
inform
breadth
kinet
phenotyp
virusspecif
cellular
immun
respons
ard
patient
provid
evid
tcell
appear
blood
ard
patient
first
two
week
post
onset
symptom
frequenc
increas
time
phenotyp
antigenspecif
cellular
immun
respons
balanc
tcell
blood
typic
central
memori
tcell
typic
effector
phenotyp
tempt
specul
cytotox
tcell
predominantli
respons
product
ifng
wherea
virusspecif
tcell
could
respons
product
typic
cytokin
elev
level
patient
plasma
previous
correl
respiratori
failur
patient
could
detect
increas
specif
product
pbmc
stimul
peptid
pool
suggest
virusspecif
tcell
blame
product
concomit
cytokin
storm
predominantli
mediat
innat
immun
cell
novel
vaccin
current
develop
mainli
focu
surfac
glycoprotein
antigen
effici
induct
virusspecif
neutral
antibodi
show
also
potent
immunogen
induc
virusspecif
tcell
data
combin
previou
studi
nonsever
recov
patient
indic
virusspecif
tcell
could
benefici
good
clinic
outcom
collect
novel
data
import
vaccin
design
facilit
evalu
futur
vaccin
immunogen
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
author
declar
compet
interest
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
collect
centrifug
minut
plasma
aliquot
store
cellular
fraction
reconstitut
phosphatebuff
salin
pb
subject
ficol
densiti
gradient
centrifug
pbmc
wash
frozen
fetal
bovin
serum
fb
dimethyl
sulfoxid
dmso
sigma
life
scienc
upon
use
pbmc
thaw
imdm
lonza
belgium
supplement
fb
iu
penicillinml
streptomycinml
lonza
belgium
mm
lglutamin
lonza
belgium
medium
pbmc
treat
uml
benzonas
merck
prior
use
stimul
assay
peptid
synthes
crude
materi
san
diego
ca
resuspend
dmso
pool
sequenti
lyophil
previous
report
epitop
predict
use
protein
sequenc
deriv
refer
genbank
iedb
analysisresourc
previous
describ
specif
epitop
predict
carri
use
previous
describ
approach
tepitool
resourc
iedb
similarli
previous
describ
remov
result
spike
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
briefli
elisa
plate
coat
recombin
rbd
protein
follow
block
sampl
ad
incub
hour
plate
wash
secondari
hrplabel
rabbit
antihuman
igg
dako
ad
follow
hour
incub
plate
wash
signal
develop
use
tmb
measur
well
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
analysi
perform
use
legendplex
analysi
softwar
distinguish
differ
analyt
basi
bead
size
intern
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
dye
quantiti
respect
cytokin
calcul
basi
intens
streptavidin
pe
signal
freshli
prepar
standard
curv
statist
analysi
comparison
tcell
percentag
ratio
stimul
tcell
cytokin
level
hc
patient
log
transform
data
test
normal
distribut
distribut
normal
group
compar
via
unpair
test
distribut
normal
group
compar
via
mannwhitney
test
twotail
p
valu
report
throughout
manuscript
one
way
anova
repeat
measur
use
test
linear
trend
sequenti
time
point
day
post
inclus
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
control
cmv
peptid
phytohemagglutinin
includ
posit
control
j
activ
stimul
could
observ
almost
pbmc
sampl
patient
wherea
activ
observ
healthi
control
hc
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
